The IBM Retirement Fund Lowers Position in Hill-Rom Holdings Inc (HRC)

The IBM Retirement Fund Lowers Position in Hill-Rom Holdings Inc (HRC)

IBM Retirement Fund lowered its stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 6.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,161 shares of the medical technology company’s stock after selling 450 shares during the period. IBM Retirement Fund’s holdings in Hill-Rom Holdings were worth $382,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the stock. FMR LLC boosted its stake in shares of Hill-Rom Holdings by 45.0% in the second quarter. FMR LLC now owns 5,017,977 shares of the medical technology company’s stock valued at $253,157,000 after buying an additional 1,557,285 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Hill-Rom Holdings by 3.5% in the second quarter. Vanguard Group Inc. now owns 4,356,236 shares of the medical technology company’s stock valued at $219,773,000 after buying an additional 149,095 shares in the last quarter. BlackRock Fund Advisors boosted its stake in shares of Hill-Rom Holdings by 12.0% in the second quarter. BlackRock Fund Advisors now owns 2,352,117 shares of the medical technology company’s stock valued at $118,664,000 after buying an additional 252,239 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Hill-Rom Holdings by 3.7% in the second quarter. Franklin Resources Inc. now owns 1,631,400 shares of the medical technology company’s stock valued at $82,304,000 after buying an additional 57,700 shares in the last quarter. Finally, Fisher Asset Management LLC boosted its stake in shares of Hill-Rom Holdings by 3.2% in the third quarter. Fisher Asset Management LLC now owns 1,627,296 shares of the medical technology company’s stock valued at $100,860,000 after buying an additional 50,761 shares in the last quarter. 82.09% of the stock is owned by institutional investors.

Hill-Rom Holdings Inc (NYSE:HRC) traded down 1.20% during trading on Wednesday, hitting $59.42. 521,131 shares of the company traded hands. The firm has a 50 day moving average of $56.38 and a 200 day moving average of $56.71. Hill-Rom Holdings Inc has a one year low of $42.99 and a one year high of $63.12. The firm has a market cap of $3.90 billion, a P/E ratio of 31.95 and a beta of 1.15.

Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings results on Thursday, November 3rd. The medical technology company reported $1.18 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.05. The business earned $706 million during the quarter, compared to the consensus estimate of $701.39 million. Hill-Rom Holdings had a net margin of 4.67% and a return on equity of 18.93%. The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.89 EPS. On average, analysts expect that Hill-Rom Holdings Inc will post $3.78 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, December 30th. Investors of record on Friday, December 16th were given a $0.17 dividend. The ex-dividend date was Wednesday, December 14th. This represents a $0.68 annualized dividend and a dividend yield of 1.14%. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 36.76%.

Separately, Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research note on Wednesday, September 21st.

In related news, COO Carlyn D. Solomon sold 40,515 shares of the company’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $54.78, for a total value of $2,219,411.70. Following the completion of the sale, the chief operating officer now owns 22,163 shares in the company, valued at approximately $1,214,089.14. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is currently owned by corporate insiders.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Related posts

Leave a Comment